Publicaciones

  • Potential biomarkers for the diagnosis of patients with fibrotic hypersensitivity pneumonitis. .Silvia Sánchez-Díez, Xavier Muñoz, David Espejo, Susana Gómez-Ollés, Iñigo Ojanguren, Christian Romero-Mesones, María-Jesús Cruz. European Respiratory Journal 2023 62: PA3802; DOI: 10.1183/13993003.congress-2023.
  • Potential Biomarkers for the Diagnosis of Patients With Lung Fibrosis.Cruz, M. J., Sanchez Diez, S., Espejo, D., Ojanguren, I., Romero-Mesones, C., & Munoz, X. American Thoracic Society, 2023. A4822-A4822.
  • Sigma-1 receptor modulation fine-tunes KV1. 5 channels and impacts pulmonary vascular function. Vera-Zambrano, A., Baena-Nuevo, M., Rinné, S., Villegas-Esguevillas, M., Barreira, B., Telli, G., ... & Cogolludo, A. (2023). Pharmacological Research, 189, 106684.
  • Quantitative image analysis of fibrillar collagens reveals novel diagnostic and prognostic biomarkers and histotype-dependent aberrant mechanobiology in lung cancer. Almici, E., Arshakyan, M., Carrasco, J. L., Martínez, A., Ramírez, J., Enguita, A. B., ... & Alcaraz, J. (2023). Modern Pathology, 36(7), 100155.
  • Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension. Blanco, I., Marquina, M., Tura-Ceide, O., Ferrer, E., Ramírez, A. M., Lopez-Meseguer, M., ... & Barberà, J. A. (2023). Frontiers in Pharmacology, 14, 1145994.
  • Obese Asthma Phenotype Is Associated with hsa-miR-26a-1-3p and hsa-miR-376a-3p Modulating the IGF Axis. Gil-Martínez, M., Lorente-Sorolla, C., Rodrigo-Muñoz, J. M., Naharro, S., García-de Castro, Z., Sastre, J., ... & Del Pozo, V. (2023). International Journal of Molecular Sciences, 24(14), 11620.
  • Two lung immuno-endotypes in IPF associated with diferent pathological features. T Cruz, N Mendoza, S Casas, G Noel, F Hernandez, M Molina, M Rojas, A Agusti, J Sellares, R Faner. ERJ Open Research Mar 2023, 9 (suppl 10) 95; DOI: 10.1183/23120541.LSC-2023.95.
  • Mesenchymal Stem Cells from COPD Patients Are Capable of Restoring Elastase-Induced Emphysema in a Murine Experimental Model. Río, C.; Jahn, A.K., Martin-Medina, A., Calvo Bota, A.M., De Francisco Casado, M.T., Pont Antona, P.J., Gigirey Castro, O., Carvajal, Á.F., Villena Portella, C., Gómez Bellvert, C., et al. Int. J. Mol. Sci. 2023, 24, 5813.
  • Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids. . Gil-Martínez, M., Lorente-Sorolla, C., Rodrigo-Muñoz, J. M., Lendínez, M. Á., Núñez-Moreno, G., de la Fuente, L., ... & Del Pozo, V. (2023). International Journal of Molecular Sciences, 24(2), 1611.
  • Bronchial aspirate-based profiling identifies microRNA signatures associated with COVID-19 and fatal disease in critically ill patients. Molinero, M., Benítez, I. D., González, J., Gort-Paniello, C., Moncusí-Moix, A., Rodríguez-Jara, F., ... & Gonzalo-Calvo, D. Frontiers in medicine, 3093, February 2022.
  • Identification of Different Lung Immune Phenotypes in Idiopathic Pulmonary Fibrosis (IPF). In D101. Cruz, T., Mendoza, N., Casas-Recasens, S., Hernandez-Gonzalez, F., Albacar, N., Sembrat, J., ... & Faner, M. R. TRANSLATIONAL AND BASIC SCIENCE ADVANCES IN PULMONARY FIBROSIS (pp. A5332-A5332). American Thoracic Society, January 2022.
  • Telomere length but not mitochondrial DNA copy number is altered in both young and old COPD. Casas-Recasens, S., Mendoza, N., López-Giraldo, A., Garcia, T., Cosio, B. G., Pascual-Guardia, S., ... & Faner, R. Frontiers in medicine, 2110, November 2021.
  • Nanoparticle transfer biosensors for the non-invasive detection of SARS-CoV-2 antigens trapped in surgical face masks. Andreu Vaquer, Alejandra Alba-Patiño, Cristina Adrover-Jaume, Steven M. Russell, María Aranda, Marcio Borges, Joana Mena, Alberto del Castillo, Antonia Socias, Luisa Martín, María Magdalena Arellano, Miguel Agudo, Marta Gonzalez-Freire, Manuela Besalduch, Antonio Clemente, Enrique Barón, Roberto de la Rica. Sensors and Actuators B: Chemical 330, October 2021.
  • Optimized detection of lung IL-6 via enzymatic liquefaction of low respiratory tract samples: application for managing ventilated patients. Antonio Clemente, Alejandra Alba-Patiño, Giulia Santopolo, Enrique Barón, Estrella Rojo-Molinero, Antonio Oliver, Jon Pérez-Bárcena, Paz Merino de Cos, María Aranda, Alberto del Castillo, Antonia Socias, Marcio Borges and Roberto de la Rica. Analyst, September 2021.
  • Lung DNA methylation in chronic obstructive pulmonary disease: relationship with smoking status and airflow limitation severity. Casas-Recasens, S., Noell, G., Mendoza, N., Lopez-Giraldo, A., Garcia, T., Guirao, A., ... & Faner, R. American Journal of Respiratory and Critical Care Medicine, 203(1), 129-134, August 2021.
  • Immunodetection of lung IgG and IgM antibodies against SARS-CoV-2 via enzymatic liquefaction of respiratory samples from COVID-19 patients. Clemente, A., Alba-Patiño, A., Santopolo, G., Rojo-Molinero, E., Oliver, A., Borges, M., ... & De La Rica, R. Analytical Chemistry, 93(12), 5259-5266, August 2021.
  • miR-144-3p Is a Biomarker Related to Severe Corticosteroid-Dependent Asthma. Rodrigo-Muñoz JM, Gil-Martínez M, Lorente-Sorolla C, García-Latorre R, Valverde-Monge M, Quirce S, Sastre J, Del Pozo V. Front Immunol 13:858722, April 2021.
  • Paper biosensors for detecting elevated IL-6 levels in blood and respiratory samples from COVID-19 patients. Cristina Adrover-Jaume, Alejandra Alba-Patiño, Antonio Clemente, Giulia Santopolo, Andreu Vaquer, Steven M. Russell, Enrique Barón, María del Mar González del Campo, Joana M. Ferrer, María Berman-Riu, Mercedes García-Gasalla, María Aranda, Marcio Borges, Roberto de la Rica. Sensors and Actuators B: Chemical 330, March 2021.
  • Detection of anti-SARS-CoV-2 antibodies in dried blood spots utilizing manual or automated spot extraction and electrochemiluminescence immunoassay (ECLIA). Andre Knoop, Hans Geyer, Oliver Lerch, Ana Rubio, Yvonne Schrader, Mario Thevis. Analytical science advances, March 2021.
  • Detection of the EGFR G719S Mutation in Non-small Cell Lung Cancer Using Droplet Digital PCR. Esteva-Socias M, Enver-Sumaya M, Gómez-Bellvert C, Guillot M, Azkárate A, Marsé R, Sastre Ú, Blasco A, Calabuig-Fariñas S, Asensio VJ, Terrasa J and Obrador-Hevia A. Front. Med. 7:594900, November 2020.
  • Analysis of copy number alterations reveals the lncRNA ALAL-1 as a regulator of lung cancer immune evasion. Athie, A., Marchese, F. P., González, J., Lozano, T., Raimondi, I., Juvvuna, P. K., ... & HuarteM. Journal of Cell Biology, 219(9), June 2020.
  • Impact of different stabilization methods on RT-qPCR results using human lung tissue samples. Margalida Esteva-Socias, Fernando Gómez-Romano, José Antonio Carrillo-Ávila, Alicia Loreto Sánchez-Navarro & Cristina Villena. Scientific reports, February 2020.
  • The MEGA Project: A Study of the Mechanisms Involved in the Genesis and Disease Course of Asthma. Asthma Cohort Creation and Long-Term Follow-Up. Munoz X, Álvarez-Puebla MJ, Arismendi E, Arochena L, del Pilar Ausín M, Barranco P, Bobolea I, Cañas JA, Cardaba B, Crespo A. Arch Bronconeumol 54(7):378-385, 2018.
  • Tumor-associated metabolic and inflammatory responses in early stage non-small cell lung cancer: Local patterns and prognostic significance. Millares L, Barreiro E, Cortese R, Martinez-Romero A, Balcells C, Cascante M, Enguita AB, Alvarez C, Rami-Port R, Sánchez de Cos J, Seijo L, Monsó E, Grupo Colaborativo en Cáncer de Pulmón CIBERES- CIBERONC- SEPAR - Plataforma Biobanco Pulmonar. Lung Cancer 122:124-130, August 2018.
  • Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy. Chalela R, Gea J, Curull V, Enríquez-Rodríguez CJ, Pijuan L, Bellosillo B. J Thorac Dis. Aceptado Mayo 2017.
  • Integrative Genomics of Emphysema Associated Genes Reveals Potential Disease Biomarkers. Obeidat M, Nie Y, Fishbane N, Li X, Bossé Y, Joubert P, Nickle DC, Hao K, Postma DS, Timens W, Sze MA, Shannon CP, Hollander Z, Nq RT, McManus B, Miller BE, Rennard S, Spira A, Hackett TL, Lam W, Lam S, Faner R, Agustí A, Hogg JC, Sin DD, Paré PD. Am J Respir Cell Mol Biol. 2017 May 1.
  • The inflammasome pathway in stable COPD and acute exacerbation. Faner R, Sobradillo P, Noguera A, Gomez C, Cruz T, López-Giraldo A, Ballester E, Soler N, Arostegui JI, Pelegrín P, Rodriguez-Roisin R, Yagüe J, Cosio B, Juan M, Agustí A. ERJ Open Res. 2016 Jul;2(3). pii: 00002-2016. eCollection 2016.
  • Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in Emphysema. Faner R, Cruz T, Casserras T, López-Giraldo A, Noell G, Coca I, Tal-Singer R, Miller B, Rodriguez-Roisin R, Spira A, Kalko SG, Agustí A. Am J Respir Crit Care Med. 2016 Jun 1;193(11):1242-53.
  • Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer. Puchades-Carrasco L, Jantus-Lewintre E, Pérez-Rambla C, García-García F, Lucas R, Calabuig S,  Blasco A, Dopazo J, Camps C, Pineda-Lucena A. Oncotarget 2016 Mar;15;7(11):12904-16.
  • Prevalence of molecular changes in surgically resected pulmonary adenocarcinomas. Chalela R, Bellosillo B, Curull V, Pijuan L, Gea J. Eur Respir J. London, 2016; 48 (suppl 60): 78.
  • Metabolomics by NMR Facilitates the Non-Invasive Diagnosis and Staging of NSCLC. Pérez-Rambla C, Puchades-Carrasco L, Jantus-Lewintre E, García-García F, Lucas R, Calabuig S, Blasco A, Dopazo J, Camps C, Pineda-Lucena A. Journal of Thoracic Oncology. Volume 10, Number 9, Supplement 2, September 2015.
  • Biological Marker Analysis as Part of the CIBERES-RTIC Cancer-SEPAR Strategic Project on Lung Cancer. Monsó E, Montuenga LM, Sánchez de Cos J, Villena C. Arch Bronconeumol. 2015 Sep;51(9):462–467.
  • An investigation of the resolution of inflammation (catabasis) in COPD. Noguera A, Gomez C, Faner R, Cosio B, González-Périz A, Clària J, Carvajal A, Agustí A. Respir Res. 2012 Nov 13;13:101.
  • Angiotensin signalling in pulmonary fibrosis. Uhal BD, Li X, Piasecki CC, Molina-Molina M. Int J Biochem Cell Biol 2012 March;44(3):465–468.
  • The CIBERES Pulmonary Biobank Consortium: an opportunity for cooperative international respiratory research. Villena C, Pozo F, Barberà JA, Vaquer P, Agusti A; CIBERES Pulmonary Biobank Consortium (PBC). Eur Respir J. 2011 Jan;37(1):204-6.

  • Effects of tumor stroma and inflammation on survival of stage I-IIp lung cancer. Millares L, Alcaraz J, Benchea I, Carrasco J, Sanchez de Cos J, Gonzalez-Castro MA, Blanco A, Sanchez-Gil R, Serra M, Rami R, Sauleda J, Fernandez E,  Melchor R, Seijo L, de Esteban Julvez L, Barreiro E, Monsó E, on behalf of Collaborative Group in Lung Cancer CIBERES-RTICC-SEPAR-Plataforma Biobanco Pulmonar. Comunicación presentada en la European Respiratory Society Congress, Milán, Italia, Septiembre 2017.
  • Valor pronóstico de la composición del estroma en el cáncer de pulmón estadio I-IIp. Millares L, Alcaraz J, Benchea I, Carrasco J, Sanchez de Cos J, Gonzalez-Castro MA, Blanco A, Sanchez-Gil R, Serra M, Rami R, Sauleda J, Fernandez E,  Melchor R, Seijo L, de Esteban Julvez L, Barreiro E, Monsó E, en representación del Grupo Colaborativo en Cáncer de Pulmón CIBERES-RTICC-SEPAR-Plataforma Biobanco Pulmonar. 50º Congreso Español, Sociedad Española de Neumología y Cirugía Torácica, Madrid, España, Junio 2017.
  • Mutaciones somáticas en parénquima pulmonar sano de pacientes con adenocarcinoma pulmonar. Chalela R, Curull V, Bellosillo B, Pijuan L, Longarón R, Badenes D, Gea J. 50º Congreso Español, Sociedad Española de Neumología y Cirugía Torácica, Madrid, España, Junio 2017.
  • Somatic driver mutations in normal lung parenchyma in patients with localized pulmonary adenocarcinoma. Chalela R, Bellosillo B, Pijuan L, Badenes D, Rodríguez-Fuster A, Curull V, Gea J. American Thoracic Society Conference, Washington, USA, Mayo 2017.
  • Somatic driver mutations in normal lung parenchyma in patients with localized pulmonary adenocarcinoma. Chalela R. 1eras Jornadas de Investigación Básica en Neumología, Badalona, España, Marzo 2017. Premio a la tercera mejor comunicación de las 1eras Jornadas de Investigación Básica en Neumología.
  • Efecte de l'estructura estromal i la inflamació tumoral sobre la supervivència del pacient amb càncer de pulmó estadi I-IIp. Millares L, Alcaraz J, Benchea I, Carrasco J, Sanchez de Cos J, Gonzalez-Castro MA, Blanco A, Sanchez-Gil R, Serra M, Rami R, Sauleda J, Fernandez E,  Melchor R, Seijo L, de Esteban Julvez L, Barreiro E, Monsó E, en representació del Grup Col•laboratiu en Càncer de Pulmó CIBERES-RTICC-SEPAR-Plataforma Biobanco Pulmonar. XXXV Diada Pneumològica de la Societat Catalana de Pneumologia, Abril 2017.
  • Network based meta-analysis of lung, sputum and blood transcriptomics in COPD. Faner R, Morrow J, Noell G, Lopez-Giraldo A, Cruz T, Tal-Singer R, Miller BE, Rodríguez-Roisin R, Silverman EK, Agusti A, Hersh CP. ERS. London, 2016.
  • Desarrollo de un modelo preclínico de Enfermedad Pulmonar Obstructiva Crónica (EPOC) en ratones inmunodeficientes y posterior tratamiento con células madre adultas. Rio C, Jahn A, Iglesias A, de Francisco T, Gigirey O, Torrecilla JA, Carvajal A, Verdú J, Gómez C, Sala-Llinas E. II Jornadas IDISPa Noviembre 2015.
  • Are Mesenchymal Stem Cells Suitable for Lung Therapy? Rio C, Jahn A, Iglesias A, Gigirey O, Torrecilla JA, Carvajal A, Sala-Llinas E. International meeting on Regenerative medicine. London, June 2015.
  • Functional and molecular differences between mesenchymal stem cells from various pulmonary diseases. Rio C, Jahn A, Martí P, Iglesias A, Fueyo L, Gigirey O, Torrecilla JA, Carvajal A, Balaguer C, Noguera A, Peralta A, Ortiz L, Sala-Llinàs E. Annual ERS Congress. Munchen 2014.
  • Caspase-1 regulated cytokines in Chronic Obstructive Pulmonary Disease. Faner R, et al. XXXVII Congreso Nacional de la Sociedad Española de Inmunologia, Salamanca (2013).
  • Análisis de la capacidad funcional de las células madre mesenquimales (MSCs) de la médula ósea de pacientes con EPOC estable. Jahn A, Río C, Gigirey O, Balaguer C, Fueyo L, Torrecilla JA, Noguera A, Duran MA, Dosanjos S, Llull R, Ortiz LA, Sala E.Abstract presentado en el 46 Congreso Nacional SEPAR (Barcelona). Junio 2013.
  • Bone Marrow-derived MSCs from patients with COPD have abnormal functional capacity. Jahn A, Rio C, Gigirey O, Fueyo L, Balaguer C, Noguera A, Torrecilla JA, Durán MA, Dosanjos S, Llull R, Ortiz LA, Sala E. European Respiratory Society (ERS) Annual Congress. Barcelona 2013.
  • Expresión de la eritropoyetina y de su receptor (Epo-R) en tejido pulmonar de pacientes con EPOC. Balaguer C, Iglesias A, Rodríguez M, Carvajal A, Ríos A, Cosío BG, Río C, Durán MA, Agustí A, Sala E. 46 Congreso Nacional SEPAR, Barcelona (2013).
  • The NLRP3 inflammasome in COPD. Faner R, et al. European Congres of Immunology. Glasgow (2012).
  • Riboleukograma en la Enfermedad Pulmonar Obstructiva Crónica. González N, et al. 45º Congreso Nacional SEPAR, Madrid (2012).
  • Riboleukograma en la Enfermedad Pulmonar Obstructiva Crónica. González N, et al. XXX Diada Pneumològica, Congrés de la Societat Catalana de Pneumologia, Sant Joan d'Espí (2012).
  • Glycoproteins and matrix metallo proteinases gene expression in parenchymal lung disease. Estany S, Vicens V, Escobar I, Manresa F, Dorca J, Molina-Molina M. The 17th International Colloquium on Lung and Airway Fibrosis (ICLAF), Modena (2012).
  • Disminución de la expresión del receptor de la eritropoyetina en las células endoteliales progenitoras circulantes de pacientes con EPOC estable. Balaguer C, Sala E, Cosío B, Jahn A, Ríos A, Iglesias A, Agustí A. 44º Congreso Nacional SEPAR. Oviedo. Junio 2011. Arch Bronconeumol 2011 (Libro de abstracts).
  • The Expression Of Erythropoietin Receptor In Circulating Endothelial Progenitor Cells Is Reduced In Patients With Stable Chronic Obstructive Pulmonary Disease. Sala E, Cosio BG, Jahn A, Balaguer C, Rios A, Iglesias A, Villena C, Agustí A. Am J Respir Crit Care Med 183;2011: A3003.
  • Lung extracellular matrix profile of patients with idiopathic pulmonary fibrosis. Estany S, Vicens V, Llatjos R, Penin R, Escobar I, Moya J, Gabasa M, Xabuet A, Manresa F, Dorca J, Molina-Molina M. Am J Respir Cri tCare Med. 2011;183;A3561. Congreso de la American Thoracic Society (ATS), 2011.
  • Multiparametric characterization of immuno-molecular profiles in small cell lung cancer. Ángel Núñez Buiza, Tesis Doctoral, Universidad Complutense de Madrid.
  • Characterization of the Pulmonary and Systemic Immune response in relation to lung stem cells in patient with COPD. Tamara Cruz Santacruz, Tesis Doctoral, Universitat de Barcelona.
  • The detection and characterization of partial deletions of the human mitochondrial genome in lung tissue of patients with asthma and chronic obstructive pulmonary disease. Angela Steinmann, Honours thesis for the Bachelor of Biotechnology, University of Wollongong, Australia.
  • Identification and characterization of large deletions of the mitochondrial genome in the lungs of asthmatics and sufferers of chronic obstructive pulmonary disease. Erin Treadwell, Honours thesis for the Bachelor of Science (Advanced), University of Wollongong, Australia.